Log in

NASDAQ:ARTC - ArthroCare Stock Price, Forecast & News

Notice: This company has been marked as potentially delisted and may not be actively trading.
$1.42
0.00 (0.00 %)
(As of 11/20/2019)
Add
Today's Range
$1.42
Now: $1.42
$1.49
50-Day Range
$1.48
MA: $1.61
$1.76
52-Week Range N/A
Volume3.86 million shs
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
ArthroCare Corporation (ArthroCare) is a medical device company. ArthroCare develops and manufactures surgical devices, instruments, and implants. Its devices enable surgical procedures and enable new minimally invasive procedures. Many of ArthroCare's devices use its Coblation technology. This technology dissolves target tissue and limits damage to surrounding healthy tissue. Read More…

Industry, Sector and Symbol

Industry N/A
Sub-IndustryHealth Care Equipment
SectorN/A
Current SymbolNASDAQ:ARTC
CUSIP04313610
Phone+1-512-3913900

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

EmployeesN/A
Next Earnings DateN/A
OptionableNot Optionable

Receive ARTC News and Ratings via Email

Sign-up to receive the latest news and ratings for ARTC and its competitors with MarketBeat's FREE daily newsletter.


ArthroCare (NASDAQ:ARTC) Frequently Asked Questions

What is ArthroCare's stock symbol?

ArthroCare trades on the NASDAQ under the ticker symbol "ARTC."

Has ArthroCare been receiving favorable news coverage?

News stories about ARTC stock have trended positive recently, InfoTrie reports. InfoTrie scores the sentiment of press coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. ArthroCare earned a coverage optimism score of 2.4 on InfoTrie's scale. They also assigned media coverage about the medical device company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the stock's share price in the immediate future. View News Stories for ArthroCare.

Who are some of ArthroCare's key competitors?

What other stocks do shareholders of ArthroCare own?

Who are ArthroCare's key executives?

ArthroCare's management team includes the folowing people:
  • Gayle Wiley, Chief Human Resource Officer, Senior Vice President
  • Jean A. Woloszko M.D., Ph.D., Senior Vice President - Research and Development, Chief Technology Officer (Age 56)
  • Richard W. Rew II, Senior Vice President, General Counsel, Secretary (Age 49)
  • Scott Schaffner, Senior Vice President, General Manager - Sports Medicine (Age 44)
  • Fred B. Dinger III, Senior Vice President, General Manager of ENT
  • James L. Pacek, Senior Vice President - Global Markets and Sales Operations (Age 65)
  • Bruce C. Prothro, Chief Regulatory Officer, Senior Vice President - Quality Systems and Assurance (Age 52)
  • Fabiana Lacerca-Allen, Independent Director (Age 47)

What is ArthroCare's stock price today?

One share of ARTC stock can currently be purchased for approximately $1.42.

What is ArthroCare's official website?

The official website for ArthroCare is http://www.arthrocare.com/.

How can I contact ArthroCare?

ArthroCare's mailing address is 7000 W William Cannon Dr, AUSTIN, TX 78735-8509, United States. The medical device company can be reached via phone at +1-512-3913900.


MarketBeat Community Rating for ArthroCare (NASDAQ ARTC)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  136 (Vote Outperform)
Underperform Votes:  136 (Vote Underperform)
Total Votes:  272
MarketBeat's community ratings are surveys of what our community members think about ArthroCare and other stocks. Vote "Outperform" if you believe ARTC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ARTC will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 12/13/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel